News & Updates
Filter by Specialty:
Adjuvant palbociclib + ET does not improve outcomes vs ET alone in early breast cancer
Adjuvant palbociclib in combination with endocrine therapy (ET) does not improve invasive disease-free survival (iDFS) or secondary endpoints vs ET alone in patients with hormone receptor–positive, HER2-negative early breast cancer, final results of the phase III PALLAS trial have shown.
Adjuvant palbociclib + ET does not improve outcomes vs ET alone in early breast cancer
15 Dec 2021
Cutting first-day dexamethasone dose not recommended for breast cancer patients on anthracycline
In breast cancer patients treated with anthracycline-containing regimens, reducing the first-day dose of dexamethasone does not yield significant gastrointestinal benefit and is not recommended for nausea management, a recent study has found.
Cutting first-day dexamethasone dose not recommended for breast cancer patients on anthracycline
11 Dec 2021
High meat intake ups risk of lung cancer
A diet with increased consumption of fruits, vegetables, breakfast cereals, and dietary fibre, as well as low intake of red and processed meat, appears to reduce the risk of lung cancer, suggests a study.
High meat intake ups risk of lung cancer
10 Dec 2021
Alcohol abstinence lowers HCC risk in patients with cirrhosis
Abstinence from alcoholic drinks reduces the risk of hepatocellular carcinoma (HCC) in patients with alcohol-related liver cirrhosis, but not in those with a history of decompensated disease, reveals a study.
